Design of a Phase IIb, randomized, controlled, double-blind, multi-centre study to evaluate the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanaian, Burkinabe and Gabonese children aged 12-60 months

Detalles Bibliográficos
Autores principales: Noor, Ramadhani A, Thiesen, Michael, Mordmuller, Benjamin, Milligan, Paul, Atuguba, Frank, Sirima, Sodiomon, Issifou, Saadou, Bojang, Kalifa, Kironde, Fred, Tiono, Alfred, Okech, Brenda, Chilengi, Roma, Ngoa, Ateba, Mukasa, Kaddu, Jepsen, Soren
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963266/
http://dx.doi.org/10.1186/1475-2875-9-S2-P26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963266/
http://dx.doi.org/10.1186/1475-2875-9-S2-P26

Ejemplares similares